[Clinical trial of a new oral mercurial diuretic (3-hydroxymercuri-2-methoxy-1-succinimido-propan-theophyllinewater) in chronic congestive heart failure].
D002908:Chronic Disease; D004232:Diuretics / Q000627:therapeutic use*; D006333:Heart Failure; D006801:Humans
D004232:Diuretics
DIURETICS/therapeutic use
Peroralt kvikksøolvdiureticum (3-hydroksymercuri-2-metoksy-1-succinimidopropan, teofyllin, H2O) brukt ved kronisk hjertesvikt en klinisk undersokelse og vurdering.